COO
Cooper Companies, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Cooper Companies, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
No changes.
No changes.
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Dec 5 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Dec 5 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 5
Same SEC industry code: Warby Parker Inc., National Vision Holdings, Inc., Staar Surgical Co and 2 more; of Cooper Companies, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 5
Same SEC industry code: Warby Parker Inc., National Vision Holdings, Inc., Staar Surgical Co and 2 more; of Cooper Companies, Inc.'s 6 closest co-movers, none share that code.
−14.67%
vs ±9.6% implied · ×1.53
shaded = implied · ▲▼ = realized
No trades yet today.
No trades yet today.
Cooper Companies, Inc.
60.83
pre 60.50 −0.54%
Tall tick = annual report · Source: EDGAR
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $1.1B | 7.22% | −9.56% |
| Vanguardindex-like | $914.9M | 6.13% | +0.31% |
| State Streetindex-like | $637.7M | 4.27% | +1.42% |
| Vanguard Portfolioindex-like | $621.7M | 4.16% | −0.59% |
| T. Rowe Price | $532.8M | 3.57% | −18.00% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $1.1B | 7.22% | −9.56% |
| Vanguardindex-like | $914.9M | 6.13% | +0.31% |
| State Streetindex-like | $637.7M | 4.27% | +1.42% |
| Vanguard Portfolioindex-like | $621.7M | 4.16% | −0.59% |
| T. Rowe Price | $532.8M | 3.57% | −18.00% |
Bull2
Bear1
Expected move
Inputsspot 60.83exp Dec 18ATM strike 60ATM straddle 7.75IV 46%